Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan.
Toft A, Urup T, Christensen IJ, Michaelsen SR, Lukram B, Grunnet K, Kosteljanetz M, Larsen VA, Lassen U, Broholm H, Poulsen HS.
Toft A, et al. Among authors: larsen va.
Cancer Invest. 2018 Feb 7;36(2):165-174. doi: 10.1080/07357907.2018.1430818. Epub 2018 Feb 2.
Cancer Invest. 2018.
PMID: 29393706
Review.